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Abstract
Background: ADs are documents in which one can state one’s preferences concerning end-of-life care, aimed at
making someone’s wishes known in situations where he/she is not able to do so in another manner. There is still a
lot unclear about ADs. We designed a study aimed at investigating the whole process from the formulating of an
AD to its actual use at the end of life.
Methods/Design: The study has mixed methods: it’s longitudinal, consisting of a quantitative cohort-study which
provides a framework for predominantly qualitative sub-studies. The members of the cohort are persons owning
an AD, recruited through two Dutch associations who provide the most common standard ADs in the Netherlands,
the NVVE (Right to Die-NL), of which 5561 members participate, and the NPV (Dutch Patient Organisation), of
which 1263 members participate. Both groups were compared to a sample of the Dutch general public. NVVE-
respondents are more often single, higher educated and non-religious, while amongst NPV-respondents there are
more Protestants compared to the Dutch public. They are sent a questionnaire every 1,5 year with a follow-up of
at least 7,5 years. The response rate after the second round was 88% respectively 90% for the NVVE and NPV.
Participants were asked if we were allowed to approach close-ones after their possible death in the future. In this
way we can get insight in the actual use of ADs at the end of life, also by comparing our data to that from the
Longitudinal Aging Study Amsterdam, whose respondents generally do not have an AD.
Discussion: The cohort is representative for people with an AD as is required to study the main research
questions. The longitudinal nature of the study as well as the use of qualitative methods makes it has a broad
scope, focusing on the whole course of decision-making involving ADs. It is possible to compare the end of life
between patients with and without an AD with the use of data from another cohort.
Background
Medicine has made a lot of progress the last ages, with
an exponential development in the 20th century. As a
result there are answers to problems that remained
unsolved in the past. Life-expectancy has grown, at least
in the Western world. But besides solving problems, this
also created new ones. With its expansion, medicine
increasingly interfered in living and, even more so,
dying. Where there used to be no choice, nowadays dif-
ficult decisions have to be made. Patients are alive in
situations where they otherwise would have passed
away, which creates dilemmas where length and quality
of life sometimes seem to be competing with each
other. For instance, the decision to start with artificial
feeding in the advanced stage of a critical illness might
e n a b l eap a t i e n tt ol i v el o n g e rw h i l ea tt h es a m et i m ei t
might lengthen the period of discomfort that the disease
will cause. These choices are personal ones, depending
on what an individual considers to be the most valuable
in living and dying.
Personal preferences can be put down in an advance
directive (AD), a written statement concerning possible
end-of-life decisions to be made in the future. This
document is aimed at stating someone’sw i s h e sw h e n
he/she is in the situation that he/she is not capable to
do so verbally or to emphasize uttered present wishes,
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ments about receiving or refusing certain treatments at
the end of life, or appoint a person who will take deci-
sions for the patient in question - a healthcare proxy.
ADs might become increasingly important in the pro-
cess of decision-making at the end of life. Yet, there is
still a lot unclear about ADs. At the moment you could
say this has created a controversy about the usefulness
of ADs. An argument made in favor of ADs is that the
documents or the choices made by proxies reflect
patient’s wishes and in that way enhance the quality of
living and dying at the end of life [1-3]. On the other
h a n dt h e r ea r ed o u b t si fap e r s o ni sa b l et om a k ea
sound choice about possible end-of-life issues in the
future [4,5] or that an appointed proxy is able to take
decisions according to another person’s preferences [6].
This contributes to the more skeptical sound that is also
heard concerning ADs [7-9].
Whether ADs work as they are supposed to or not,
they exist and they are used. Especially about the use of
ADs, there is still a lot unclear, particularly while it is
difficult doing research on this matter because it brings
along several ethical and practical issues. The study
described here, was designed in order to get a better
insight into how decisions are made at the end of life
focusing on ADs. It takes place in the Netherlands.
This article focuses on how this study was set up in
order to investigate the broad spectrum of research
questions related to the whole process ranging from for-
mulating an AD, possibly as a healthy individual, to the
eventual use of an AD in case of serious illness (table
1). The design will be explained as well as the recruit-
ment, measurements and sub-studies. Finally a descrip-
tion of the respondent groups in relation to the general
Dutch public will be given.
Methods/Design
Design cohort study of people with an advance directive
Mixed methods are used. Central in this study is a pro-
spective quantative cohort-study (fig. 1). The studied
population consists of people who have formulated one
of the common types of standard ADs in the Nether-
lands. For the entire cohort data are collected by means
of a written questionnaire every one and a half year.
The follow-up will be at least seven and a half years.
The cohort provides a quantitative framework from
which it is possible to select subgroups for predomi-
nantly qualitative sub-studies. An important added value
of qualitative studies is to get better insight in certain
mechanisms, for instance why end-of-life preferences
change. Furthermore it is possible to identify other fac-
tors influential on choices at the end of life than the
ones already identified by the quantitative study, because
of the open view by which qualitative research is
characterized.
The data generated by the cohort can be compared
w i t ht h ed a t af r o mo t h e rs t u d i e sl i k eas a m p l eo ft h e
general Dutch population and the Longitudinal Aging
Study Amsterdam (LASA). Both will be discussed later
in this article, LASA in connection with the study on
the use of ADs at the end of life for which relatives of
deceased respondents are approached.
Recruitment
As to include as much people possible who have an AD,
we asked the help from the two associations that pro-
vide the most common types of standard ADs in the
Netherlands. The ‘Right to Die-NL’ (NVVE in Dutch) is
a society that is engaged in the supposed right of an
individual to have extensive control over the last phase
of his/her life, thus broader than euthanasia alone. They
provide three types of standard ADs.
The first, a refusal of treatment document, is an AD
where a person states that he/she doesn’t wish to receive
life-prolonging treatment in the case where his/her qual-
i t yo fl i f ei sb e l o waf o rh i m / h e ra c c e p t a b l el e v e la n d
there is no chance that it will improve. The second is
the advance euthanasia directive (AED). Euthanasia is
allowed by law in the Netherlands, making it a subject
of decision-making at the end of life. The AED is a
document, where a person declares that he wants to
receive euthanasia in situations where he suffers
Table 1 Research Questions
Subject Research Questions
Formulating an AD What are people’s preferences at the end of their lives?
What are reasons to formulate (or not formulate) an AD?
Having an AD Do the preferences concerning a person’s end of life change over time and does he/she modify his/her AD accordingly
if they do?
What are the expectations concerning ADs and end-of-life decision-making among people who have an AD and do they
discuss this with their physician or others?
The Use of ADs Are the directions in ADs followed at the end of life in the situations where they relate to?
If they are followed, what are the reasons therefore?
If they are not followed, how do they influence the end of life of the person in question?
What is the role of physicians and family or close-ones in this process?
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situations can be specified in the AD. AEDs are specifi-
cally mentioned as a legitimate request for euthanasia in
the Euthanasia Act, which allows - but does not require -
a physician to grant a patient’s wish to end his/her life
in case other requirements are met as well.
Finally there is the AD where someone appoints a per-
son who will take (medical) decisions for him when he
is no longer able to - a healthcare proxy.
In 2005 90.637 members of the NVVE had requested
a standard AD. An estimate of seventy-five percent of
them actually completed the AD, but the exact figure is
not known.
The other association, the Dutch Patient Association
(NPV in Dutch), a Christian orientated patient association,
provides the second most common standard AD in the
Netherlands. This is a so-called wish-to-live statement,
where a person declares that he/she wants to receive
proper care, meaning no excessive, medically useless treat-
m e n t sa tt h ee n do fh i sl i f eb u ta l s on oa c t i o n sw i t ht h e
purpose of actively terminating his life. In this way he/she
expresses his/her wish to die in a dignified and respectful
manner. The NPV, unlike the NVVE, has on file which
members actually completed an AD. In 2005, 5812 mem-
bers of the NPV had a wish-to-live statement.
A random sample of people was taken from the mem-
bership files of both associations. This sample consisted
of people who at some point in the past had requested
one of the standard AD’s of the NVVE or had com-
p l e t e daw i s h - t o - l i v es t a t e m e n to ft h eN P V .T h e yw e r e
sent questionnaires which also contained a question
about if they would be willing to participate in an inter-
view if selected for a (qualitative) sub-study. If selected,
the specific participant got a request to give written
consent before being interviewed.
In addition they were asked if they were willing to give
the name and contact information of two relatives. In
the event of their death or incompetence, these relatives
c o u l db ea p p r o a c h e ds o m et i m ea f t e r w a r d si no r d e rt o
learn more about the circumstances at the end of life,
t h ed e c i s i o n - m a k i n gi n v o l v e da n dt h er o l et h eA D
played in all of this. Off course the relatives are first
informed about our study and asked to give written con-
sent before participating.
In case a respondent wasn’t able to fill in the ques-
tionnaire by him/herself because of physical constraints
for instance, we also presented the possibility to com-
plete it by means of an interview by phone.
It is important that the cohort is large enough to con-
tain a sufficient number of people whose (health)
Cohort 
Quantative Framework 
Study subjects related to 
ADs; such as: 
- Dementia & drafting ADs 
- Reasons for drafting ADs   
- Changes in end-of-life 
preferences 
Other end-of-life subjects, 
such as: 
-  Personal Dignity at the 
end of life 
-  Not granted requests for 
euthanasia 
-  Persons with a wish to die 
Qualitative Sub-studies 
People with AD  People without AD 
 
Sample Dutch 
Population 
& 
LASA* 
 
Relatives of 
deceased 
cohort 
members 
 
Relatives of 
deceased 
LASA* 
members 
After a 
cohort 
member 
deceases 
Comparison 
Comparison 
Figure 1 Scheme of the design of the study. * LASA = Longitudinal Aging Study Amsterdam.
van Wijmen et al. BMC Public Health 2010, 10:166
http://www.biomedcentral.com/1471-2458/10/166
Page 3 of 9situation is changing and go through their last phase of
life. Since no relevant data are available, it was not pos-
sible to make a power calculation. It was therefore
decided to form a large cohort. We now know that
between the start of the study and the second time par-
ticipants were sent a questionnaire after one and a half
year in total 276 of them had passed away. This is a
sign that over the years of follow-up the cohort will pro-
duce enough data on changes in health status and dif-
ferent situations at the end of life.
From the NVVE 13.005 members were asked to parti-
cipate in the longitudinal study, of whom 5.561 (43%)
actually did participate (fig. 2). The people who gave a
reason why they did not participate (N = 1770), most
often said they found the subject too confronting (32%).
Other grounds often heard were that people had no
time or interest (26%) or too bad health (17%). When
the second questionnaire was sent one and a half year
later, the response rate was 88% (N = 4.665). The people
who had deceased in the intermediate period (N = 258,
5% from the 5.561 original participants), are not
included in this calculation. For the majority of the 12%
that did not participate in the second round, the reason
why was unknown.
From the NPV 3000 members were asked to partici-
pate, from which 1263 (42%) actually agreed to do so
(fig. 3). From the 58% (N = 1.737) that did not want to
take part, the same two reasons as with the NVVE were
heard most often as to why this was the case: the sub-
ject was too confronting (36%) or that they had no time
or interest (16%). The third motivation heard most fre-
quently differs from the NVVE: the subject was too per-
sonal for 11% of the members of the NPV who did not
want to participate.
When they were sent a questionnaire for the second
time, 90% (N = 1.119) from the original participants
responded. Again, the 18 persons who had deceased in
the meanwhile were not included in the calculation of
this response rate.
Although these figures are still preliminary, we can
also say something about the response rates of the third
round 3 years after the start of the study. For the NVVE
Asked to participate 
N = 13.005 
t1
Participated in 1st 
round 
N = 5.561* (43%) 
Did not participate 
N = 7.444 (57%), from which: 
Non-response Non-response Deceased
with reason      unknown           before 
N = 1770          reason               able to  
-Too confronting      N = 5280          reply
(32%)                                                 
- No time/interst                                     N = 394 
(26%) 
- Bad health 
(17%) 
- Other (25%) 
Participated in 
2nd round (t2)
N = 4.665 (88%)
Did not participate in 2
nd round 
N = 638 (12%), from which:      
Moved,                    Unknown 
end mem- reason            
bership NVVE                               
or other  
reason 
N = 165                     N = 473        
Deceased 
between t1 & t2 
N = 258 (5%)
Figure 2 Flowchart of recruitment and response of members from the NVVE. * This number consist of people who actually had drawn up
an AD and the ones who had only requested one from the NVVE, but had not yet completed it (N = 1.059).
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83% (N = 1.043) (both rates based on the number of
original participants). At least a fourth, fifth and sixth
round will follow in the next years.
Ethical approval and confidentiality
The Medical Ethics Review Committee of the VU Uni-
versity Medical Center approved the study. Anonymity
of the participants was guaranteed where possible. The
questionnaires were sent by the two associations
involved using their membership files. They were
returned to the researchers using only the respondent
number. That way the researchers did not get to know
the respondent’s name and address. The only exceptions
were subjects who had agreed to give up their anonym-
ity, should they be selected for one of the qualitative
sub-studies.
Measurements
In order to answer the questions posed by the objectives
of this study, an extensive questionnaire was drawn up
for the first measurement. It consists of five sections: (1)
personal characteristics, (2) personality, (3) health status
and quality of life, (4) wishes concerning the end-of-life
and (5) ADs. A participant’s personality was evaluated
using part of the Neurotics-Extroversion-Openness Five
Factor Inventory (NEO-FFI), a questionnaire to test per-
sonality. In the section about health status and quality
of life, the EQ-5D was taken up. This is a standardized
instrument to measure health status.
The questionnaires of the follow-up are focused on
changes in health status, life-events, quality of life,
wishes concerning the end of life and ADs. There is a
possibility to add questions relevant to other studies in
a follow-up measure. The first follow-up questionnaire
for instance included the PDI (ref chochinov Dignity
revisited) for use in a study on personal dignity at the
end of life.
Nested sub-studies
The data originating from the questionnaires could also
be used to select groups for the qualitative sub-studies,
which consist of in-depth interviews. These sub-studies
focus on people with dementia, people with a wish to
Asked to participate 
N = 3000
t1
Participated in 1st 
round 
N = 1.261 (42%)
Did not participate 
N = 1.737 (58%), from which: 
Non-response  Non-response
with reason unknown            
N = 514                           reason               
-Too confronting N = 1.223          
(36%)
- No time/interst                                  
(16%) 
- Too personal 
(11%)
Participated in 
2nd round (t2)
N = 1.119 (90%)
Did not participate in 2
nd round 
N = 124 (10%), from which:      
Moved, 
end mem- Unknown
bership NPV           reason          
or other  
reason 
N = 70                      N = 54          
Deceased 
between t1 & t2 
N= 18 (1%)
Figure 3 Flowchart of recruitment and response of members from the NPV.
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AD’s and dignity in the light of specific diseases (like
dementia or cancer).
Study on the use of ADs at the end of life
As to investigate how the process of decision-making at
the end of life took place and what role the AD had
played, respondents were asked in the questionnaires if
the researchers were allowed to approach family or
close-ones in case the respondent would pass away dur-
ing follow up. If family members or close-ones agreed to
cooperate with the study after a specific respondent had
deceased, they were sent a questionnaire focused on the
last phase in the life of the departed.
To get a complete image of the role ADs play at the
end of life, we wanted to evaluate both situations in
which there was an AD present and in which there was
not. We had the possibility to collaborate with the
Longitudinal Aging Study Amsterdam (LASA). This is
a study focusing on several aspects of aging. Partici-
pants, who are representative for the older Dutch
population, are interviewed every three years. Besides
that parts of our questionnaire were presented to parti-
cipants in LASA, their family or close-ones were
approached in the same way after they had died as with
the members of our cohort, so that it was possible to
get a look into the process of end-of-life decision-mak-
ing without an AD.
Comparison with Dutch public
Although it was not essential in order to be able to
answer the main research questions formulated in table 1,
we wanted to compare the data from the cohort with
the general Dutch population as to look where people
with an AD stand in relation to the Dutch population
when it comes to background characteristics and views
on end-of-life issues. In order to do this parts of the
questionnaire used for the Advance Directives cohort
were sent to an established sample of the Dutch public:
the Consumers’ panel for Health services of the Nether-
lands Institute for Health Services Research (in Dutch:
NIVEL). This sample is designed to be representative of
the population of the Netherlands of 20 years and older.
From the original sample of 1621 persons, 1402 people
returned the questionnaire, which makes a response rate
of 86%. The respondents were representative for the
Dutch population for age, but men were somewhat
underrepresented (44% versus 49%), as were first and sec-
ond generation migrants (7% versus 19% in the general
Dutch population in 2005 according to Statistics
Netherlands).
Table 2 gives an overview of background characteris-
tics from the respondents from the NVVE, NPV and the
Consumers’ p a n e li no r d e rt og e ta no u t l i n eo ft h e
differences between the groups. We split the respon-
dents in a group with the age below 65 years and one
above, because age is a possible confounder, for instance
regarding marital status (more widowed persons in
older age categories). This may lead to a selection bias
when it comes to the NVVE- and NPV-respondents
because they are on average older compared to the Con-
sumers panel (respectively 67.8 (95% CI 67.5-68.1) and
59.6 (58.6-60.6) versus 50.6 (49.9-51.4)). It can be
n o t i c e dt h a tb o t ht h er e s p o n d e n t sf r o mt h eN V V Ea n d
NPV differ from the general Dutch population on sev-
eral other points as well.
NVVE-respondents are more often single, higher edu-
cated and non-religious. The majority of NPV-respon-
dents are supporters of the protestant belief, compared
to approximately one quarter of the Dutch public. The
older respondents on average have a lower education.
When it comes to more specific characteristics it is
clear that the younger respondents from the NVVE have
more health problems compared to the Consumers’
panel. Regarding a case that was presented to the
respondents about preferences when suffering from
advanced stage cancer, a significantly larger part of the
NPV-respondents stated they wanted to be resuscitated
in case of a cardiac arrest compared to the Dutch
Public.
From the three characteristics from the NEO-FFI the
mean scores are presented. A person who completes the
questionnaire gets a score on each of these three charac-
teristics ranging from 12 (low) and 60 (high). As can be
seen in table 1, the mean scores scarcely differ between
the different groups.
Analysis
From the comparison on background characteristics
between the three groups described above follows that
the data originating from the NPV and NVVE cannot
be merged, but rather has to be analyzed separately,
because the differences between these two groups are so
substantial.
Descriptive and multivariate regression analyses will
be used to determine associations between patient char-
acteristics, motivations and expectations of people.
Longitudinal data analysis will be used to determine
changes in time within a person regarding preferences.
Qualitative research data analysis starts during the
data-collection. In this way, the already gathered data
will shape the ongoing data collection in order to refine
questions and develop and test hypotheses. These types
of analyses are called sequential analyses.
Discussion
The response in the first round was fairly low with 43% of
the NVVE-members and 42% of the NPV-members who
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Page 6 of 9Table 2 Background characteristics of members of the cohort (NVVE and NPV) and a sample of the Dutch population
in 2005 (rounded percentages with 95% confidence intervals).
Members of the NVVE
(n = 5561)
Members of the NPV
(n = 1261)
Sample of the Dutch population
(n = 1402)
< 65 yrs.
(40%)
> 65 yrs.
(60%)
< 65 yrs.
(54%)
> 65 yrs.
(46%)
< 65 yrs.
(80%)
> 65 yrs.
(20%)
Gender
- Male 32 (30-34) 39 (37-40) 38 (34-42) 42 (38-47) 40 (38-43) 60 (55-65)
- Female 68 (66-70) 61 (60-63) 62 (58-66) 58 (53-62) 60 (57-62) 40 (35-45)
Age
(mean with 95% CI’s)
55.7 yr.
(55.3-56.0)
76.1 yr.
(75.8-76.3)
46.4 yr.
(45.4-47.4)
75.1 yr.
(74.6-75.6)
44.9 yr.
(44.2-45.5)
73.3 yr.
(72.7-73.8)
Marital status
Partner 71 (69-73) 54 (52-56) 77 (74-81) 63 (59-66) 85 (83-87) 67 (62-73)
- Married 55 (53-57) 48 (46-49) 75 (72-78) 60 (57-65) 71 (68-73) 62 (57-68)
- Living together 10 (9-11) 3 (3-4) 0.7(0.3-1.6) 0.5 (0.2-1.4) 12 (10-14) 2 (1-5)
- Otherwise 7 (6-8) 3 (3-4) 1 (1-3) 1 (1-3) 3 (2-4) 3 (1-5)
Single 29 (27-31) 46 (44-48) 23 (19-26) 37 (34-42) 15 (13-17) 33 (27-38)
- Divorced 9 (8-11) 7 (6-8) 3 (2-4) 3 (2-4) 5 (4-7) 8 (5-11)
- Widowed 8 (7-9) 33 (32-34) 2 (1-4) 25 (21-29) 2 (2-3) 22 (17-27)
- Otherwise 12 (10-13) 6 (5-7) 17 (15-20) 10 (8-12) 7 (6-9) 3 (2-6)
Children
- Children, good relation 59 (57-61) 74 (73-76) 68 (65-71) 71 (67-75) 72 (70-75) 78 (73-83)
- Children, bad relation (with some or all) 6 (5-7) 11 (10-12) 4 (3-6) 14 (11-17) 5 (4-6) 12 (8-16)
- No children 35 (33-37) 15 (14-16) 28 (25-31) 15 (13-19) 23 (20-25) 10 (7-13)
Education
- Elementary or basic vocational 11 (10-12) 19 (17-20) 24 (21-27) 49 (45-53) 19 (17-22) 34 (29-40)
- Secondary 29 (27-31) 32 (30-33) 38 (35-42) 29 (25-33) 39 (37-42) 30 (25-35)
- Higher 60 (58-62) 50 (48-52) 37 (34-41) 22 (19-26) 41 (39-44) 36 (31-41)
Life stance
- No belief 69 (67-71) 60 (58-62) 1 (1-2) 1 (0-2) 47 (44-50) 24 (20-30)
- Roman Catholic 11 (10-13) 10 (9-11) 6 (4-8) 11 (8-13) 26 (24-29) 42 (36-48)
- Protestant 6 (5-7) 14 (12-15) 92 (90-94) 87 (84-90) 21 (19-24) 27 (22-33)
- Humanistic 8 (7-9) 11 (10-12) 0 (0-0.4) 0 (0-0.4) 2 (1-3) 4 (2-6)
- Other 6 (5-7) 5 (4-6) 1 (0-1) 1 (1-3) 3 (2-5) 3 (2-6)
Belief and its importance in someone’s life
- Belief important 15 (14-17) 23 (21-24) 97 (96-98) 98 (96-99) 28 (25-31) 55 (49-60)
- Belief not important
or no belief
85 (83-86) 77 (76-79) 3 (2-4) 2 (1-4) 72 (69-75) 45 (40-51)
3 Characteristics from NEO-FFI (mean scores with 95% CI’s)*
- Neuroticism 28.7
(28.3-29.0)
28.9
(28.6-29.1)
30.1
(29.5-30.7)
30.0
(29.3-30.6)
29.0
(28,6-29.4)
29.1
(28.3-29.9)
- Altruism 45.2
(44.9-45.4)
44.5
(44.3-44.7)
46.3
(45.9-46.7)
45.9
(45.5-46.3)
44.9
(44.6-45.2)
43.9
(43.4-44.5)
- Conscientiousness 46.1
(45.8-46.3)
44.8
(44.6-44.9)
45.8
(45.4-46.3)
45.0
(44.5-45.5)
45.5
(45.3-45.8)
44.7
(44.1-45.3)
Experienced health
- (Very) good 80 (78-81) 74 (73-76) 86 (83-89) 77 (73-80) 89 (87-90) 79 (74-83)
- Less than good 20 (19-22) 26 (24-27) 14 (11-17) 23 (20-27) 11 (9-13) 21 (17-26)
Suffering from a disease
- Yes 49.5 (47-52) 68 (66-69) 39 (36-43) 65 (61-69) 33 (31-36) 61 (55-66)
- No 50.5 (48-53) 32 (31-34) 61 (57-65) 35 (31-39) 67 (64-69) 39 (34-45)
Resuscitation in case of cardiac arrest when suffering from advanced stage cancer
- (Probably) yes 2 (1-3) 4 (3-4) 47 (43-51) 46 (42-51) 12 (10-14) 20 (16-25)
- (Probably) no 98 (97-99) 96 (96-97) 53 (49-57) 54 (49-58) 88 (86-90) 80 (75-84)
* The Neurotics-Extroversion-Openness Five Factor Inventory (NEO-FFI), a questionnaire to test personality, has normally 5 characteristics. We only used 3, because
these were the ones most relevant for our research. A respondent who filled in the questionnaire got a score on each characteristic that could range from1 2t o6 0 ;
12 meaning they scored very low on that specific characteristic and 60 that they scored very high. We took the mean score per respondent group.
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Page 7 of 9were approached responding. There were some factors
that may explain these rates. The membership files with
information about addresses from both associations were
somewhat outdated. Sometimes the ADs were requested
quite some time before and moving house was not always
reported. With respect to the NVVE, members often
requested an AD when they were already seriously ill. This
made that they were either not in the mental or physical
state to be able to respond to an invitation to participate
in a study or they were possibly committed to a hospital
or other care establishment which compromised a
response. Members of the NPV were on average younger
as compared to their counterparts from the NVVE, which
possibly made that they were less occupied with issues
concerning the end of life. While the response in the first
round was low, the response in the follow-up was high for
both groups, which is a fact of importance when it comes
to a cohort study.
A limitation of this study is that the two groups in our
cohort are not entirely representative for the part of the
Dutch population who possesses an AD, because it
l e a v e so u tp e r s o n sw h od on o to w nas t a n d a r dA D ,b u t
did draw one up for themselves. Self-written ADs are
legally binding in the Netherlands as well. Nevertheless,
standard ADs make up for the majority of used ADs in
the Netherlands (65%) [10]. Moreover, recruiting people
through the two associations, the NVVE and NPV,
made that we were able to approach and include a large
number of persons who actually possess an AD. Partici-
pants in the cohort are generally people who put more
profound thought and contemplation into end-of-life
issues and the drawing-up of an AD, which enhances
the quality of the data. Another advantage is that we
were able to design a prospective study, which is a great
strength. Although it is not necessary in order to answer
the main research questions, we did assess how our
population, people who own an AD, was related to the
general Dutch public. This gives valuable information,
especially when the cohort is used in order to study
end-of-life topics not directly related to ADs.
The size and design make that this study stands out.
Most research on this subject was done in the US,
w h e r et h ek n o w l e d g ea b o u tA D si sp r o m o t e db yt h e
Patient Self Determination Act what makes the Ameri-
can situation concerning ADs exceptional compared to
the rest of the world. The studies performed in the US
vary in size and quality, among which the SUPPORT
study stands out because of its size and design [7,11-16].
Outside of the US, studies on this subject were in gen-
eral smaller and not longitudinal [17-19].
This study has a broad scope focusing on the whole
course of decision-making involving ADs from formula-
tion, possible changes along the way and the actual use
at the end of life. Besides this, the possibility to compare
our data with other studies with related subjects also
adds to the value of this study. With this study we hope
to find some answers to long-lasting questions sur-
rounding a broad scale of subjects concerning ADs.
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